This article explores the anticancer effects of salinomycin, a compound originally used as an antibiotic, in breast cancer. The study highlights salinomycin's ability to target breast cancer stem cells, inhibit tumor growth, and induce apoptosis through multiple mechanisms, including oxidative stress and mitochondrial dysfunction. The article discusses potential clinical applications,
